Close

Oncothyreon (ONTY) CEO Robert Kirkman Retires; Christopher Henney Named Interim CEO

January 11, 2016 8:01 AM EST Send to a Friend
Oncothyreon Inc. (Nasdaq: ONTY) announced that Robert L. Kirkman, M.D., has retired as president and CEO and as a member ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login